Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog.
Hofland
L J
LJ
Department of Internal Medicine, Section Endocrinology, Erasmus MC, Rotterdam, The Netherlands. l.hofland@erasmusmc.nl
D000222:Adaptation, Physiological; D000818:Animals; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D006801:Humans; D010902:Pituitary Gland / Q000378:metabolism; D015175:Prolactinoma / Q000188:drug therapy* / Q000378:metabolism*; D017481:Receptors, Somatostatin / Q000145:classification / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013618:Tachyphylaxis / Q000502:physiology
D017481:Receptors, Somatostatin; D013004:Somatostatin